ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LDOS Leidos Holdings Inc

142.85
0.00 (0.00%)
Pre Market
Last Updated: 12:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Leidos Holdings Inc NYSE:LDOS NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 142.85 25 12:00:00

Leidos Names Jason Albanese As New Health Group Business Development Lead

29/11/2018 11:15am

PR Newswire (US)


Leidos (NYSE:LDOS)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Leidos Charts.

RESTON, Va., Nov. 29, 2018 /PRNewswire/ -- Leidos (NYSE: LDOS), a FORTUNE 500® science and technology leader, announced today that Jason Albanese has been named the Leidos Health Group's senior vice president of business development. Mr. Albanese will develop and manage the $2 billion plus group's overall business strategy, maintain a healthy pipeline of business opportunities, and create strategic partnerships to meet objectives. 

 

LEIDOS LOGO

 

Mr. Albanese has 17 years of experience in various Lockheed Martin and Leidos roles spanning engineering, program management, and business development. Most recently, he was the Vice President of Business Development for the Defense Group's Operations & Logistics Solutions where the team demonstrated very strong growth over the last two years, winning several large opportunities and penetrating new markets.  At Lockheed Martin, he led a team of more than 100 capture and business development professionals responsible for all new business pursuits across the company's Information Systems & Global Solutions enterprise, which merged with Leidos in 2016. He was also responsible for leading cross-corporate campaigns and strategies focused on Department of Defense, Intelligence Community, Homeland Defense and Homeland Security programs and initiatives.

"Over his career, Jason has consistently demonstrated a strong strategic approach to business as well as leadership and mentoring abilities that will serve the corporation well in this expanded role," said Roy Stevens, Leidos Executive Vice President and Chief of Business Development and Strategy. "Jason's engineering and program management background will serve him well in this new role as he partners with the existing Health leadership team to bring continued innovation to the health markets."

Jason holds a Master's in Systems Engineering from the University of Pennsylvania, a Master's in Business Administration from the Robert H. Smith School of Business at the University of Maryland and an undergraduate degree from Villanova University in electrical engineering. He is a graduate of the Lockheed Martin Engineering Leadership Development Program, the Executive Development and Growth Enhancement Program, and the Program Management Development Program.

About Leidos
Leidos is a Fortune 500® information technology, engineering, and science solutions and services leader working to solve the world's toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company's 32,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $10.17 billion for the fiscal year ended December 29, 2017. For more information, visit www.Leidos.com.

Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company's Annual Report on Form 10-K for the period ended December 29, 2017, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.

Contact:    

Melissa Koskovich                                                                                                   


(571) 526-6850        


Koskovichm@Leidos.com  

 

Cision View original content:http://www.prnewswire.com/news-releases/leidos-names-jason-albanese-as-new-health-group-business-development-lead-300757361.html

SOURCE Leidos

Copyright 2018 PR Newswire

1 Year Leidos Chart

1 Year Leidos Chart

1 Month Leidos Chart

1 Month Leidos Chart

Your Recent History

Delayed Upgrade Clock